A Study to Investigate Effect of Clarithromycin, a Strong CYP3A4 Inhibitor, on Brensocatib Pharmacokinetics in Healthy Participants
Clinical trial NCT05965570 · COMPLETED
Trial details
- NCT number
- NCT05965570
- Sponsor
- Insmed Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2023-09-22
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.